1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, February 2017 (p7)

Biological Therapy Analysis & Statistics, February 2017 (p7)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

181-210 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy, Healthcare
  • Countries : World

Acute Lung Injury Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Lung Injury Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H1, 2017” provides an overview of Acute Lung ...

  • Industries : Chronic Disease, Biological Therapy, Pathology, Biotechnology
  • Countries : World

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Cancer, Pathology
  • Countries : World, United States

Global Human Embryonic Stem Cell (hESC) Research - Biotechnology

  • $ 4200
  • Industry report
  • February 2017
  • by Global Industry Analysts

This report analyzes the Global market for Human Embryonic Stem Cell (hESC) Research in US$ Million. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics ...

  • Industries : Biological Therapy
  • Countries : United States, Europe

Synergys Biotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Synergys Biotherapeutics Inc (Synergys Biotherapeutics) is an early stage company that develops targeted antibody biotherapeutic products for treatment of various solid tumors. The company’s ...

  • Industries : Biological Therapy
  • Countries : United States

Stem Cell Theranostics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Stem Cell Theranostics Inc (Stem Cell Theranostics) is a biotechnology company that develops genetically-targeted therapies for heart failure. The company discovers and develops novel medicines ...

  • Industries : Biological Therapy

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017" provides an overview ...

  • Industries : Health Services
  • Countries : World

Oxford BioTherapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Oxford BioTherapeutics Ltd (Oxford BioTherapeutics) is a biotechnology company that develops antibody drug conjugates (ACDs) for the treatment of variety of cancers. The company’s OGAP technology ...

  • Industries : Biological Therapy

Protalix BioTherapeutics Inc (PLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s pipeline products include PRX-102, a ...

  • Industries : Pharmaceutical

Progenitor Cell Therapy LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Progenitor Cell Therapy LLC (PCT), a subsidiary of Caladrius Biosciences Incis an external development and manufacturing company that offers cell therapy products. The company offers services that ...

  • Industries : Biological Therapy
  • Countries : United States

Europe Stem Cell Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 3850
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The European stem cell market is one of the most rapidly growing markets. The market is currently valued at USD 4.2 billion and is expected to grow at a CAGR of 15.7% over a forecast period. EuropeStem ...

  • Industries : Biological Therapy
  • Countries : Europe

Global Stem Cell Therapeutics Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global stem cells market is one of the most rapidly growing markets. The market is currently valued at USD14 billion and is expected to grow at a CAGR of 13.7% over the forecast period. The CAGR of ...

  • Industries : Biological Therapy
  • Countries : World

Global 3D Cell culture Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global 3D Cell culture market was valued at an estimated $XX million in 2013 and is poised to grow at a CAGR of XX% from 2013 to 2018, to reach $XX million by 2018. The market is expected to reach ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : United States, World

Regenerative Medicine Market by Therapy, Product, Applications - Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

“Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World, Europe, North America, United States

Human Embryonic Stem Cells (hESC) Market Analysis By Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Country (U.S., UK, Germany, Japan, China), And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • February 2017
  • by Grand View Research

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source ...

  • Industries : Biological Therapy
  • Countries : World

2017-2021 Emerging Opportunities in the Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape

  • $ 3500
  • Industry report
  • February 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan

RNAi Technology - Market size, segmentation, market share and competitive landscape (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global market for RNAi technology is estimated to be USD 12.56 billion in 2016 and is expected to reach USD 31.52 billion by 2022, growing at a CAGR of 20.19% RNA interference (RNAi) is a natural process ...

  • Industries : Biological Therapy
  • Countries : World

North America Regenerative Medicines Market - Growth, Trends, and Forecasts (2017 - 2022)

  • $ 3850
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The North American regenerative medicines market is expected to reach USD 22.5 billion by 2019, from USD 7.4 billion in 2014, growing at a CAGR of 17.7%. Small molecules and biologics show immense potential ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : North America

Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • February 2017
  • by Currentpartnering

Summary The Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine ...

  • Industries : Biological Therapy, Biotechnology, Pharmaceutical, Healthcare, Pathology, Therapy, Health Services
  • Countries : United States, North America

Global Regenerative Medicine - Pharmaceuticals

  • $ 4950
  • Industry report
  • January 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World, United States, Europe

Global Stem Cell Banking Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

Stem cell is an undifferentiated cell that has potential to develop into any type of cell in the body. A stem cell bank stores these stem cells for future use. The stem cell banking market accounted to ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America

Global Stem Cell Services Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global stem cells market is one of the most rapidly growing markets. The market is currently valued at USD14 billion and is expected to grow at a CAGR of 13.7% over the forecast period. The CAGR of ...

  • Industries : Biological Therapy
  • Countries : World

Global RNAi Technology Market - Growth, Trends And Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global market for RNAi technology is estimated to be USD 8.7 billion in 2014 and is expected to reach USD21.9 billion by 2019, growing at a CAGR of 20.19% RNA interference (RNAi) is a natural process ...

  • Industries : Biological Therapy
  • Countries : World

The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities

  • $ 2365
  • Industry report
  • January 2017
  • by La Merie Publishing

The Oncolytic Virus Landscape 2017: an analysis of pipeline,stakeholders, deals, industry trends & opportunities The field of oncolytic viruses wasquite dormant in the first decade of the 2000s, characterized ...

  • Industries : Therapy, Pathology, Cancer
  • Countries : United States

Global Single Cell Analysis Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • January 2017
  • by Accuray Research LLP

The Global Single Cell Analysis Market is poised to grow at a CAGR of around 18.9% over the next decade to reach approximately $6.92 billion by 2025. Some of the prominent trends that the market is witnessing ...

  • Industries : Biological Therapy
  • Countries : World, United States

Global Stem Cell Therapy Market 2017-2021

  • $ 3500
  • Industry report
  • January 2017
  • by Infiniti Research Limited

About stem cell therapy Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies ...

  • Industries : Biological Therapy
  • Countries : Japan, World

Global Stem Cell Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global market for stem cells has been estimated at USD 12 billion in 2014 and is projected to reach USD 26.6 billion by 2020, at a CAGR of 13.7% during the forecast period 2014 to 2021. A stem cell ...

  • Industries : Biological Therapy
  • Countries : World

2017-2021 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • January 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan

Top 10 Bioprocess Technology Market by Cell Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, Tangential Flow Filtration, Virus Filtration & Region - Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021 from USD 39.30 billion in 2016, at a CAGR of 12.4% from 2016 to 2021. On the basis of type, the market is segmented ...

  • Industries : Biotechnology, Biological Therapy, In Vitro Diagnostics, Biopharmaceutical, Medical Device
  • Countries : World

Global Regenerative Medicines Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global regenerative market is estimated to reach USD 67.6 billion by 2019, from USD 16.4 billion in 2014, growing at a CAGR of 23.2 %. Small molecules and biologics show immense potential in the market ...

  • Industries : Biological Therapy
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.